TP53 and prostate cancer: Recent investigations have revealed that hSSB1 negatively regulates p53 and RNA polymerase II transcription during radiotherapy for prostate cancer, thus playing a pivotal role in mediating cellular responses to androgen signaling and DNA damage (Adams et al., 2023).